Priya Sumithran

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Long-Term Persistence of Hormonal Adaptations to Weight Loss

Priya Sumithran, Luke A. Prendergast, Elizabeth Delbridge et al. · New England Journal of Medicine · 2011 · 1.4K citations

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Ketosis and appetite-mediating nutrients and hormones after weight loss

Priya Sumithran, Luke A. Prendergast, Elizabeth Delbridge et al. · European Journal of Clinical Nutrition · 2013 · 255 citations · Full text

Obesity, Nutrition, Appetite +9

The effect of rate of weight loss on long-term weight management: a randomised controlled trial

Katrina Purcell, Priya Sumithran, Luke A. Prendergast et al. · The Lancet Diabetes & Endocrinology · 2014 · 196 citations

Obesity, Lifestyle Modification, Weight Loss +7